Literature DB >> 12823249

Living related kidney transplantation in a patient with autosomal-recessive Alport syndrome.

Ken Sakai1, Masaki Muramatsu, Hidetaka Ogiwara, Takeshi Kawamura, Kenji Arai, Atsushi Aikawa, Takehiro Ohara, Sonoo Mizuiri, Kensuke Joh, Ichiro Naito, Akira Hasegawa.   

Abstract

We discuss a patient with Alport syndrome who received a renal transplant from a donor with thin basement membrane disease. A 30-year-old woman, diagnosed with Alport syndrome on the basis of sensorineural hearing loss, characteristic renal biopsy findings and a family history of microhaematuria, entered chronic haemodialysis therapy. She then received a renal transplant donated from her father, who had sensorineural hearing loss and persistent microhaematuria. On the day of renal transplantation, a 1-h graft biopsy after reperfusion showed thin basement membrane disease. We re-tested the patient's native kidney biopsy specimen by immunohistochemical staining using alpha-chain-specific collagen type IV monoclonal antibodies. There was no expression of collagen type IV alpha3-, alpha4- and alpha5-chain on glomerular basement membrane, but positive staining of alpha5-chain on Bowman's capsular basement membrane was noted. A diagnosis of autosomal-recessive Alport syndrome was made. We concluded that this family might display different phenotypic expressions of the same genotype: one suffered end-stage renal disease and the other thin basement membrane disease.

Entities:  

Mesh:

Year:  2003        PMID: 12823249     DOI: 10.1034/j.1399-0012.17.s10.5.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

1.  Natural history of genetically proven autosomal recessive Alport syndrome.

Authors:  Masafumi Oka; Kandai Nozu; Hiroshi Kaito; Xue Jun Fu; Koichi Nakanishi; Yuya Hashimura; Naoya Morisada; Kunimasa Yan; Masafumi Matsuo; Norishige Yoshikawa; Igor Vorechovsky; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

Review 2.  Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.

Authors:  Yasar Caliskan; Krista L Lentine
Journal:  Pediatr Nephrol       Date:  2022-01-27       Impact factor: 3.651

3.  Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.

Authors:  Friederike Petzold; Anette Bachmann; Carsten Bergmann; Udo Helmchen; Jan Halbritter
Journal:  BMC Nephrol       Date:  2019-09-02       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.